ArticleAging2016

Targeting therapy for homocysteic acid in the blood represents a potential recovery treatment for cognition in Alzheimer's disease patients.

Tohru Hasegawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.